Inari Medical

Inari Medical's mission is to treat and transform the lives of patients suffering from venous and other vascular diseases by pioneering innovative, lytic-free mechanical thrombectomy solutions. The company has achieved significant commercial success, with its products used in over 100,000 patient procedures, establishing a leadership position in the large and growing VTE market. Its strategy centers on expanding its core technology platform into adjacent vascular indications, generating robust clinical evidence, and driving adoption through a comprehensive physician education and training ecosystem. Inari operates as a publicly traded, revenue-generating entity focused on capturing a greater share of the underserved VTE treatment landscape.

A modular platform for mechanical thrombectomy, utilizing specialized catheters and sheaths for the lytic-free, single-session physical removal of blood clots from veins. Core technologies include large-bore aspiration, coring/capture mechanisms, and integrated blood return systems.

Inari faces direct competition in thrombectomy from companies like Penumbra (Indigo), Boston Scientific (EKOS), and Philips (AngioVac). Its key differentiation is a focus on purely mechanical, lytic-free solutions with purpose-built devices for specific venous indications, supported by a strong educational platform (Clot Warrior Academy).